Vicks VapoCool SEVERE plus Intense Pain Relief

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name: Vicks VapoCool SEVERE plus Intense Pain Relief
Generic name: BENZOCAINE AND MENTHOL
Manufacturer: The Procter & Gamble Manufacturing Company
Product type: HUMAN OTC DRUG
SPL set ID: 38cd83db-47ca-e320-e063-6394a90aba41
SPL ID: 38cd83e9-dcd4-e654-e063-6394a90a6cd9
Version: 1
Effective date: 2025-06-30
Source export date: 2026-09-28
Source partition: 12
Source file: https://download.open.fda.gov/drug/label/drug-label-0012-of-0014.json.zip
Source object key: raw/openfda/drug-label/2026-09-28/663999d0fe1757c1e2cd13a4799d76d875f663e0bc57701092264ebe7febfc18/drug-label-0012-of-0014.json.zip
Source manifest SHA-256: cd2e66336a5cd2223fa3995098fdbdb84c6a7ee5c0a4addb236ccb22dd1e6887
Import run: 20260929T050834Z
Imported at: 2026-09-29 06:29:32

Harmonized routes table
Harmonized routes
ORAL

Harmonized identifier links#

Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.

Harmonized identifiers page 1 of 1 · 12 matching rows.

Type, Scope, Identifier table
Type	Scope	Identifier	Source field
application number		M022	openfda.application_number
brand name		Vicks VapoCool SEVERE plus Intense Pain Relief	openfda.brand_name
generic name		BENZOCAINE AND MENTHOL	openfda.generic_name
manufacturer name		The Procter & Gamble Manufacturing Company	openfda.manufacturer_name
ndc	package	84126-366-30	openfda.package_ndc
ndc	product	84126-366	openfda.product_ndc
ndc11	package	84126036630	derived:openfda.package_ndc
rxcui		1923481	openfda.rxcui
spl id		38cd83e9-dcd4-e654-e063-6394a90a6cd9	id
spl set id		38cd83db-47ca-e320-e063-6394a90aba41	set_id
unii		U3RSY48JW5	openfda.unii
unii		L7T10EIP3A	openfda.unii

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

Warnings Methemoglobinemia Warning – Use of this product may cause methemoglobinemia, a serious condition that must be treated promptly because it reduces the amount of oxygen carried in blood. This can occur even if you have used this product before. Stop use and seek immediate medical attention if you or a child in your care develops: pale, gray or blue colored skin (cyanosis) headache rapid heart rate shortness of breath dizziness or lightheadedness fatigue or lack of energy

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.